Latest Intelligence on Pharmaceuticals and Healthcare in United Kingdom

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
CommentWire
CommentWire

ADHD: NICE ruling for Ritalin, but will it boost sales?

Published By Datamonitor
02 Nov 2000
CommentWire
CommentWire

KS BioMedix: an alternative route to the marketplace

Published By Datamonitor
06 Nov 2000
CommentWire
CommentWire

Flu remedies: out in the cold

Published By Datamonitor
08 Nov 2000
CommentWire
CommentWire

Multiple sclerosis: NICE to reconsider decision

Published By Datamonitor
09 Nov 2000
CommentWire
CommentWire

Glaxo Wellcome: biomarkers make their mark

Published By Datamonitor
08 Dec 2000
CommentWire
CommentWire

Shire Pharmaceuticals: transatlantic growth spurt

Published By Datamonitor
11 Dec 2000
CommentWire
CommentWire

Vernalis: benefiting from SB's regulatory headaches

Published By Datamonitor
14 Dec 2000
Expert View
Expert View

Piggy backing on organ transplants

Published By Datamonitor
22 Dec 2000
CommentWire
CommentWire

Alzheimer's disease: has NICE finally lived up to its name?

Published By Datamonitor
23 Jan 2001
CommentWire
CommentWire

Embryo cloning: the future of neurological treatment

Published By Datamonitor
25 Jan 2001

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.